Leading Cancer Center MD Anderson Taps AI for Drug Discovery
One of the country’s leading comprehensive cancer centers has just announced that it is tapping an artificial intelligence-powered drug discovery platform to aid its development of novel cancer therapeutics. The center is working with AI developer Exscientia to aid its discovery of new cancer drugs. According to an MD Anderson press release, the collaboration will […]